Durham, NC, United States of America

William Pendergast

This inventor holds 48 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Delta Opioid Receptor Agonists. Top assignees: Inspire Pharmaceuticals, Inc., Versi Group, LLC, Glaxo Wellcome Inc.. Active years: 1995-2018.

USPTO Granted Patents = 48 

% Patents Active = 75.0



Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 684(Granted Patents)


Company Filing History:


Years Active: 1995-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Delta Opioid Receptor Agonists
Parkinson's Disease
Purinergic Receptor Agonists
Dry Eye Disease
Ciliary Dyskinesia
Pharmaceutical Formulations
Dinucleoside Polyphosphates
Sinusitis Treatment
Lung Diseases
Sexual Dysfunctions
Lower Urinary Tract Dysfunction
Tear Production
48 patents (USPTO):Explore Patents

Title: Innovations and Contributions of William Pendergast in Parkinson's Disease Treatments

Introduction

William Pendergast, a prominent inventor based in Durham, NC, has made significant strides in the field of medical science with his inventive solutions for treating Parkinson's disease. Holding an impressive portfolio of 48 patents, Pendergast has focused on developing effective therapies aimed at alleviating the negative symptoms associated with this complex neurological disorder.

Latest Patents

Among his recent contributions, Pendergast has patented methods centered on the treatment of Parkinson's disease using diarylmethylpiperazine compounds. His innovative approach entails administering therapeutically effective compounds that exhibit delta opioid receptor agonist activity, potentially coupled with mu receptor antagonist activity. These compositions and methods represent a breakthrough in reducing the adverse side effects often experienced by patients suffering from Parkinson's disease.

Career Highlights

Throughout his career, Pendergast has collaborated with established companies such as Inspire Pharmaceuticals and Versi Group. His work in these organizations has allowed him to channel his expertise into practical applications that benefit patients and advance medical research. His commitment to innovation in therapeutic treatments highlights his role as a leading inventor in the pharmaceutical field.

Collaborations

Pendergast has worked alongside notable colleagues like Janet L. Rideout and Benjamin R. Yerxa. These collaborations have fostered a productive environment rich in research and development, ultimately contributing to the successful completion and patenting of significant medical breakthroughs. The teamwork reflects the importance of collaboration in driving innovation within the medical community.

Conclusion

William Pendergast's dedication to inventing transformative medical solutions, particularly for Parkinson's disease, showcases his invaluable contributions to science and healthcare. His extensive patent portfolio and his professional alliances underscore the potential of collaborative efforts in bringing forth innovations that can enhance the quality of life for patients around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…